Abstract
A better understanding of second-line drug (SLD) pharmacokinetics, including cavitary penetration, may help optimize SLD dosing. Patients with pulmonary multidrug-resistant tuberculosis (MDR-TB) undergoing adjunctive surgery were enrolled in Tbilisi, Georgia. Serum was obtained at 0, 1, 4, and 8 h and at the time of cavitary removal to measure levofloxacin concentrations. After surgery, microdialysis was performed using the ex vivo cavity, and levofloxacin concentrations in the collected dialysate fluid were measured. Noncompartmental analysis was performed, and a cavitary-to-serum levofloxacin concentration ratio was calculated. Twelve patients received levofloxacin for a median of 373 days before surgery (median dose, 11.8 mg/kg). The median levofloxacin concentration in serum (Cmax) was 6.5 μg/ml, and it was <2 μg/ml in 3 (25%) patients. Among 11 patients with complete data, the median cavitary concentration of levofloxacin was 4.36 μg/ml (range, 0.46 to 8.82). The median cavitary/serum levofloxacin ratio was 1.33 (range, 0.63 to 2.36), and 7 patients (64%) had a ratio of >1. There was a significant correlation between serum and cavitary concentrations (r = 0.71; P = 0.01). Levofloxacin had excellent penetration into chronic...Continue Reading
References
Nov 26, 2003·Infection and Immunity·Gilla KaplanLinda-Gail Bekker
Dec 2, 2005·Expert Opinion on Pharmacotherapy·Gabriel Chong, Michael A Morse
May 4, 2006·Annals of Internal Medicine·Timothy H HoltzVaira Leimane
Apr 20, 2007·Journal of Clinical Pharmacology·Chandra S ChaurasiaHelen Yeo
Oct 31, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Hye-Ryoun KimJae-Joon Yim
Dec 12, 2007·Antimicrobial Agents and Chemotherapy·Charles A PeloquinJohn L Johnson
Jan 5, 2008·The Journal of Antimicrobial Chemotherapy·M BassettiC Viscoli
Oct 22, 2008·Journal of Biomedical Informatics·Paul A HarrisJose G Conde
Feb 28, 2009·The Lancet Infectious Diseases·Evan W OrensteinAlison P Galvani
May 13, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sekai ChideyaJordan W Tappero
Feb 17, 2010·Current Clinical Pharmacology·Véronique Dartois, Clifton E Barry
Mar 17, 2010·The Journal of Antimicrobial Chemotherapy·Veronika MatziChristian Joukhadar
Oct 19, 2010·International Journal of Antimicrobial Agents·Jayesh DhananiJohn F Fraser
Nov 18, 2010·The Journal of Antimicrobial Chemotherapy·Jörg LindenmannChristian Joukhadar
Feb 22, 2011·Analytical Chemistry·Brendan PrideauxMarkus Stoeckli
Apr 13, 2011·Clinical Microbiology Reviews·Linda M ParsonsJohn Nkengasong
Jun 7, 2011·The Journal of Antimicrobial Chemotherapy·Hong-Bin XuLing Li
Oct 25, 2011·The Journal of Infectious Diseases·Shashikant SrivastavaTawanda Gumbo
Dec 27, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Russell R KempkerSergo Vashakidze
Jan 28, 2012·The Lancet Infectious Diseases·Russell R KempkerHenry M Blumberg
Feb 22, 2012·PloS One·Nestani TukvadzeHenry M Blumberg
Sep 7, 2012·PLoS Medicine·Shama D AhujaUNKNOWN Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB
May 7, 2013·The Annals of Thoracic Surgery·Sergo VashakidzeRussell R Kempker
Aug 1, 2013·The Journal of Infectious Diseases·Jotam G PasipanodyaTawanda Gumbo
Nov 20, 2013·Antimicrobial Agents and Chemotherapy·Stellah G MpagamaScott K Heysell
Nov 26, 2013·Lancet·Alimuddin Zumla Baroness Masham of Ilton
Dec 3, 2013·The European Respiratory Journal·Onno W AkkermanJan-Willem Alffenaar
Jan 24, 2014·Clinical Pharmacokinetics·Francine Johansson AzeredoHartmut Derendorf
Apr 11, 2014·The Lancet. Respiratory Medicine·Keertan DhedaRobin Warren
Apr 29, 2014·Vaccine·UNKNOWN WHO
Citations
Nov 26, 2015·The New England Journal of Medicine·C Robert HorsburghChristoph Lange
Aug 16, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Payam NahidAndrew Vernon
Dec 1, 2017·The Journal of Antimicrobial Chemotherapy·M Tobias HeinrichsRussell R Kempker
Apr 5, 2017·Antimicrobial Agents and Chemotherapy·Russell R KempkerSergo Vashakidze
May 17, 2017·Antimicrobial Agents and Chemotherapy·Natasha Van't Boveneind-VrubleuskayaJan-Willem C Alffenaar
Nov 30, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Devyani DeshpandeTawanda Gumbo
Mar 31, 2018·The European Respiratory Journal·Galina LylesScott K Heysell
Feb 14, 2018·The European Respiratory Journal·Russell R KempkerCharles A Peloquin
Feb 21, 2019·Antimicrobial Agents and Chemotherapy·Samiksha GhimireJan-Willem C Alffenaar
Feb 2, 2019·Current Pharmaceutical Design·Jatinder Kaur Mukker, Ravi Shankar Prasad Singh
May 8, 2019·Antimicrobial Agents and Chemotherapy·Mohammad H Al-ShaerCharles A Peloquin
Sep 15, 2019·Scientific Reports·Frank KloproggeOscar Della Pasqua
Oct 21, 2016·Expert Review of Anti-infective Therapy·Jan-Willem C AlffenaarDick Van Soolingen
Dec 13, 2016·The AAPS Journal·Amelia N DeitchmanHartmut Derendorf
Aug 1, 2017·International Journal of Pharmacokinetics·Andrew D McCallum, Derek J Sloan
Feb 9, 2021·PloS One·Arto Yuwono SoerotoBony Wiem Lestari
Feb 9, 2021·Clinical Pharmacology and Therapeutics·Craig R RaynerKaren Rowland-Yeo
Apr 11, 2021·Clinical Pharmacology and Therapeutics·Charles A Peloquin, Geraint R Davies
Jun 13, 2021·Biopharmaceutics & Drug Disposition·Apinya BoonpengMaseetoh Samaeng